Developer docs
API playgroundTry for free, no card

Search company profiles

Levin Health

Full company profile

uuid000w3u1

Namestring
Levin Health
Legal namestring
Levin Health Ltd
Websiteurl
levinhealth.com.au
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Levin Health Ltd is a privately held Australian medicinal cannabis sponsor headquartered in Melbourne, founded in 2019 (with sales activity beginning around 2020-2021). The company operates a Knowledge-Heavy, Capital-Light business model, sourcing pharmaceutical-grade CBD oils, THC oils, and dried flower products from third-party manufacturers and presenting them to a cohort of nearly 500 prescribing healthcare professionals across Australia. Products are dispensed through pharmacies to patients with treatment-resistant chronic pain, anxiety, and sleep disorders. Revenue is generated on a per-unit basis via prescriptions; the company discloses $5.2M in sales (including discounts) for its most recent fiscal year with 42k units sold, up from $340K in August 2022.

Short descriptiontext

Levin Health is an Australian pharmaceutical sponsor that sources and commercialises medicinal cannabis products (CBD/THC oils and dried flower), selling them via prescriptions from nearly 500 healthcare professionals to Australian patients with chronic pain, anxiety, and sleep disorders.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMelbourne, Australia
HQ citystring
Melbourne
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medicinal cannabis, pharmaceutical-grade CBD, chronic pain treatment, alternative therapy research, cannabis product commercialisation
NAICS code2 codes
  • Medicinal and Botanical Manufacturing325411
  • Scientific Research and Development Services5417
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Services-Commercial Physical & Biological Research8731
Product category
Pharmaceutical Medicinal Cannabis
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medicinal Cannabis Product Sales
TypeHardware Sales
Description

Sale of pharmaceutical-grade CBD and THC oils and dried flower products through prescriptions written by healthcare professionals and dispensed by pharmacies to patients.

levinhealth.com.au
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Levin Health operates as a "sponsor" in the Australian medicinal cannabis supply chain, sourcing pharmaceutical-grade CBD Oils, THC Oils, and Dried Flowers from international manufacturers and commercialising them to Australian healthcare professionals for prescription to patients suffering chronic pain, anxiety, and sleep disorders. The company underwrites this distribution with clinical research, including a Phase 2 randomised controlled trial and observational studies with La Trobe University and Alternaleaf.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Levin Health offers a portfolio of pharmaceutical-grade medicinal cannabis products consisting of CBD Oils, THC Oils, and Dried Flowers spanning the CBD and THC spectrum. These products are prescribed by nearly 500 healthcare professionals across Australia for treating chronic pain, anxiety, and sleep disorders where other treatments have failed. The company operates as a sponsor in the medicinal cannabis supply chain, sourcing high-quality products from world-class manufacturers and presenting them to healthcare professionals as alternative treatment options for their patients.

Product and service3 records
1CBD Oils
CategoryMedicinal cannabis oils
Description

Pharmaceutical-grade cannabis oil products containing CBD (cannabidiol), prescribed by healthcare professionals across Australia as an alternative treatment for patients with chronic pain, anxiety, and sleep disorders where other treatments have failed.

2THC Oils
CategoryMedicinal cannabis oils
Description

Pharmaceutical-grade cannabis oil products containing THC (tetrahydrocannabinol), prescribed by healthcare professionals in Australia for treating chronic pain, anxiety, and sleep disorders where conventional treatments have not been effective.

3Dried Flowers
CategoryMedicinal cannabis flower
Description

Pharmaceutical-grade dried cannabis flower products spanning the CBD and THC spectrum, prescribed as an alternative treatment option by Australian healthcare professionals for chronic pain, anxiety, and sleep disorders.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1La Trobe University
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration with La Trobe University's Sport and Exercise Medicine Research Centre for clinical trials investigating medicinal cannabis effectiveness for chronic pain from musculoskeletal injury.

2Alternaleaf
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint Observational Study with Alternaleaf (telehealth clinic with trained practitioners specializing in plant-based medicine). Patients can book appointments with Alternaleaf to determine eligibility for the observational study.

3Emyria
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Emyria Athlete Support Program - completed study supporting research for alternative therapies.

4Releaf / Project Twenty21
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Completed Project Twenty21 study - a medicinal cannabis patient registry and research project.

5Dr Matty Moore
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Completed musculoskeletal chronic pain study.

levinhealth.com.au
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Aurora Cannabis
TypeBroad incumbent
Description

Global cannabis company with medicinal cannabis products and operations across multiple geographies including Australia. Operates as a significantly larger incumbent with broader product portfolio and capital base.

2Little Green Pharma
TypeDirect peer
Description

ASX-listed Australian medicinal cannabis producer and distributor offering pharmaceutical-grade oils and dried flower products prescribed by HCPs. Comparable sponsor/producer model operating in the same TGA regulatory framework.

3Emyria
TypeDirect peer
Description

Australian clinical drug development company with a medicinal cannabis focus; already an existing partner of Levin Health (Emyria Athlete Support Program). Highly comparable in clinical-evidence-led development approach.

4Cann Group
TypeDirect peer
Description

ASX-listed Australian medicinal cannabis company engaged in cultivation, manufacturing, and distribution of pharmaceutical-grade cannabis products. A direct competitor across the Australian supply chain.

5Althea Group Holdings
TypeDirect peer
Description

Australian medicinal cannabis company selling pharmaceutical-grade products via prescriptions and pharmacies. Directly comparable in business model, product mix, and HCP-led distribution strategy.

6Zelira Therapeutics
TypeDirect peer
Description

Australian-listed medicinal cannabis company focused on clinically validated products for chronic conditions including chronic pain and sleep disorders. Closely comparable in product focus and clinical evidence strategy.

7Bod Australia
TypeDirect peer
Description

ASX-listed Australian company developing and commercialising medicinal cannabis and health products. Comparable product portfolio and HCP distribution within the Australian market.

8Jazz Pharmaceuticals (GW Pharmaceuticals)
TypeBroad incumbent
Description

Pharmaceutical company that acquired GW Pharmaceuticals (maker of Epidiolex), representing the gold standard in clinically validated cannabis-based medicines. Relevant as a benchmark for clinical-validation-led cannabis pharma economics.

9Tilray Brands
TypeBroad incumbent
Description

Global cannabis leader with pharmaceutical and consumer cannabis portfolios including Australian distribution. A larger incumbent with overlapping medicinal cannabis products but materially broader geographic and category scope.

10Incannex Healthcare
TypeDirect peer
Description

ASX-listed Australian clinical-stage medicinal cannabis company developing pharmaceutical-grade products for chronic conditions. Comparable in clinical-trial-led development strategy and target indications.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Levin Health

Pharmaceutical Medicinal Cannabislevinhealth.com.au

Levin Health is an Australian pharmaceutical sponsor that sources and commercialises medicinal cannabis products (CBD/THC oils and dried flower), selling them via prescriptions from nearly 500 healthcare professionals to Australian patients with chronic pain, anxiety, and sleep disorders.

What Levin Health does

Levin Health Ltd is a privately held Australian medicinal cannabis sponsor headquartered in Melbourne, founded in 2019 (with sales activity beginning around 2020-2021). The company operates a Knowledge-Heavy, Capital-Light business model, sourcing pharmaceutical-grade CBD oils, THC oils, and dried flower products from third-party manufacturers and presenting them to a cohort of nearly 500 prescribing healthcare professionals across Australia. Products are dispensed through pharmacies to patients with treatment-resistant chronic pain, anxiety, and sleep disorders. Revenue is generated on a per-unit basis via prescriptions; the company discloses $5.2M in sales (including discounts) for its most recent fiscal year with 42k units sold, up from $340K in August 2022.

Levin Health firmographics

Firmographics
Name
Levin Health
Legal name
Levin Health Ltd
Website
https://levinhealth.com.au
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
Levin Health is an Australian pharmaceutical sponsor that sources and commercialises medicinal cannabis products (CBD/THC oils and dried flower), selling them via prescriptions from nearly 500 healthcare professionals to Australian patients with chronic pain, anxiety, and sleep disorders.
Ownership category
akta.pro rank

Where Levin Health is headquartered

Location

Headquarters

HQ city
Melbourne
HQ country
Australia
HQ region
Oceania

Offices2 records

Markets served

Levin Health business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

  1. Medicinal Cannabis Product Sales: Sale of pharmaceutical-grade CBD and THC oils and dried flower products through prescriptions written by healthcare professionals and dispensed by pharmacies to patients.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Levin Health product offering

Product offering

Core offering

Levin Health operates as a "sponsor" in the Australian medicinal cannabis supply chain, sourcing pharmaceutical-grade CBD Oils, THC Oils, and Dried Flowers from international manufacturers and commercialising them to Australian healthcare professionals for prescription to patients suffering chronic pain, anxiety, and sleep disorders. The company underwrites this distribution with clinical research, including a Phase 2 randomised controlled trial and observational studies with La Trobe University and Alternaleaf.

Product overview

Levin Health offers a portfolio of pharmaceutical-grade medicinal cannabis products consisting of CBD Oils, THC Oils, and Dried Flowers spanning the CBD and THC spectrum. These products are prescribed by nearly 500 healthcare professionals across Australia for treating chronic pain, anxiety, and sleep disorders where other treatments have failed. The company operates as a sponsor in the medicinal cannabis supply chain, sourcing high-quality products from world-class manufacturers and presenting them to healthcare professionals as alternative treatment options for their patients.

Differentiator

Problem solved

Functional benefit

Products and services

  • CBD Oils Pharmaceutical-grade cannabis oil products containing CBD (cannabidiol), prescribed by healthcare professionals across Australia as an alternative treatment for patients with chronic pain, anxiety, and sleep disorders where other treatments have failed.
  • THC Oils Pharmaceutical-grade cannabis oil products containing THC (tetrahydrocannabinol), prescribed by healthcare professionals in Australia for treating chronic pain, anxiety, and sleep disorders where conventional treatments have not been effective.
  • Dried Flowers Pharmaceutical-grade dried cannabis flower products spanning the CBD and THC spectrum, prescribed as an alternative treatment option by Australian healthcare professionals for chronic pain, anxiety, and sleep disorders.

Companies that use Levin Health

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Levin Health technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Levin Health partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • La Trobe UniversitycoreStrategic or Co-development PartnerCollaboration with La Trobe University's Sport and Exercise Medicine Research Centre for clinical trials investigating medicinal cannabis effectiveness for chronic pain from musculoskeletal injury.
  • AlternaleafcoreStrategic or Co-development PartnerJoint Observational Study with Alternaleaf (telehealth clinic with trained practitioners specializing in plant-based medicine). Patients can book appointments with Alternaleaf to determine eligibility for the observational study.
  • EmyriaminorStrategic or Co-development PartnerEmyria Athlete Support Program - completed study supporting research for alternative therapies.
  • Releaf / Project Twenty21minorStrategic or Co-development PartnerCompleted Project Twenty21 study - a medicinal cannabis patient registry and research project.
  • Dr Matty MooreminorStrategic or Co-development PartnerCompleted musculoskeletal chronic pain study.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Levin Health competitors and assessment

Company assessment

Broad incumbents

  • Aurora Cannabis: Global cannabis company with medicinal cannabis products and operations across multiple geographies including Australia. Operates as a significantly larger incumbent with broader product portfolio and capital base.
  • Jazz Pharmaceuticals (GW Pharmaceuticals): Pharmaceutical company that acquired GW Pharmaceuticals (maker of Epidiolex), representing the gold standard in clinically validated cannabis-based medicines. Relevant as a benchmark for clinical-validation-led cannabis pharma economics.
  • Tilray Brands: Global cannabis leader with pharmaceutical and consumer cannabis portfolios including Australian distribution. A larger incumbent with overlapping medicinal cannabis products but materially broader geographic and category scope.

Direct peers

  • Little Green Pharma: ASX-listed Australian medicinal cannabis producer and distributor offering pharmaceutical-grade oils and dried flower products prescribed by HCPs. Comparable sponsor/producer model operating in the same TGA regulatory framework.
  • Emyria: Australian clinical drug development company with a medicinal cannabis focus; already an existing partner of Levin Health (Emyria Athlete Support Program). Highly comparable in clinical-evidence-led development approach.
  • Cann Group: ASX-listed Australian medicinal cannabis company engaged in cultivation, manufacturing, and distribution of pharmaceutical-grade cannabis products. A direct competitor across the Australian supply chain.
  • Althea Group Holdings: Australian medicinal cannabis company selling pharmaceutical-grade products via prescriptions and pharmacies. Directly comparable in business model, product mix, and HCP-led distribution strategy.
  • Zelira Therapeutics: Australian-listed medicinal cannabis company focused on clinically validated products for chronic conditions including chronic pain and sleep disorders. Closely comparable in product focus and clinical evidence strategy.
  • Bod Australia: ASX-listed Australian company developing and commercialising medicinal cannabis and health products. Comparable product portfolio and HCP distribution within the Australian market.
  • Incannex Healthcare: ASX-listed Australian clinical-stage medicinal cannabis company developing pharmaceutical-grade products for chronic conditions. Comparable in clinical-trial-led development strategy and target indications.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Levin Health social profiles

Digital presence

Levin Health compliance and trust

Trust signal

Compliance1 record

Levin Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Levin Health leadership team

Management profile

Number of profiles

Profiles4 records

Levin Health funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Levin Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Levin Health

What does Levin Health do?

Levin Health operates as a "sponsor" in the Australian medicinal cannabis supply chain, sourcing pharmaceutical-grade CBD Oils, THC Oils, and Dried Flowers from international manufacturers and commercialising them to Australian healthcare professionals for prescription to patients suffering chronic pain, anxiety, and sleep disorders. The company underwrites this distribution with clinical research, including a Phase 2 randomised controlled trial and observational studies with La Trobe University and Alternaleaf.

Is Levin Health a public or private company?

Levin Health is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Levin Health founded?

Levin Health was founded in 2019. It employs 1 to 10 people.

Where is Levin Health based?

Levin Health is headquartered in Melbourne, Australia, in the Oceania region.

How does Levin Health make money?

One revenue line is on record: medicinal Cannabis Product Sales.

Who are Levin Health's main competitors?

Broad incumbents on record are Aurora Cannabis, Jazz Pharmaceuticals (GW Pharmaceuticals) and Tilray Brands. Direct peers are Little Green Pharma, Emyria, Cann Group, Althea Group Holdings, Zelira Therapeutics, Bod Australia and Incannex Healthcare.

Does Levin Health have an API?

No public API is recorded for Levin Health.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireExperts Might Have Found a Better Way to Cultivate Medicinal Cannabis in AustraliaLevin Health and CSIRO conducted a six-month study on Australian medicinal cannabis cultivation, funded by a $50,000 grant. Researchers found potassium application could be cut by up to 50% in some environments, potentially lowering costs and environmental impact. The industry is valued at $67 million and projected to reach $936.22 million by 2032.GlobeNewswireLevin Health Explains the Process of Prescribing Medicinal CannabisLevin Health explains that Australian medicinal cannabis requires TGA approval via a doctor, with eligibility assessed case-by-case after other treatments fail. The process takes about two business days, and only doctors or nurse practitioners can obtain prescriptions.GlobeNewswireLegal Use of Medicinal Cannabis on the Rise in AustraliaLevin Health reports that prescribed medicinal cannabis use in Australia rose from 2.7% to 37.6% between 2018-2019, with 841,000 Australians accessing it legally by September 2022. The CAMS-20 study found prescribed users spend $70.20 AUD weekly versus $58.60 for illicit users, though cost remains a barrier.GlobeNewswireExperts Say Medicinal Cannabis in Australia is Becoming More AffordableLevin Health reports that 47% of Australian medicinal cannabis users find it too expensive, with average weekly costs at $79. Domestic cultivation is rising, with 66 licenses awarded by May 2022, and the average price per mg dropped 12% between March and September 2021.GlobeNewswirePatient Demand for Medicinal Cannabis in Australia Continues to GrowLevin Health reports that patient demand for medicinal cannabis in Australia grew by 50% between Q1 and Q3 2021 as stigma dissolves. Over 307,000 SAS-B applications have been approved, and product availability doubled from 2020 to 2021. Sales are expected to reach $423 million by year-end, while average individual spend dropped to $278 per month.